Lido Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$227K Sell
4,713
-488
-9% -$22.8K ﹤0.01% 1718
2025
Q4
$247K Buy
5,201
+217
+4% +$10.8K ﹤0.01% 1672
2025
Q3
$235K Sell
4,984
-695
-12% -$33.5K ﹤0.01% 1611
2025
Q2
$274K Sell
5,679
-331
-6% -$16.9K ﹤0.01% 1379
2025
Q1
$333K Sell
6,010
-1,028
-15% -$55.6K ﹤0.01% 1166
2024
Q4
$339K Sell
7,038
-26
-0.4% -$1.32K ﹤0.01% 1159
2024
Q3
$407K Buy
7,064
+584
+9% +$31.5K ﹤0.01% 1028
2024
Q2
$314K Buy
6,480
+76
+1% +$3.67K ﹤0.01% 1096
2024
Q1
$311K Buy
6,404
+345
+6% +$16.8K ﹤0.01% 1081
2023
Q4
$301K Buy
6,059
+1,090
+22% +$53.3K ﹤0.01% 1032
2023
Q3
$267K Buy
4,969
+1,125
+29% +$60K ﹤0.01% 967
2023
Q2
$207K Buy
+3,844
New +$207K ﹤0.01% 1091

Other funds holding SNY

Lido Advisors's SNY Position: Q1 2026 in Review

Lido Advisors reduced its Sanofi (SNY) stake by 9.4% in Q1 2026, selling an estimated $22.8K and leaving 4,713 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Lido Advisors first reported a position in SNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $407K in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Lido Advisors held 4,713 shares of Sanofi worth $227K as of Q1 2026.
  • Lido Advisors sold 488 Sanofi shares in Q1 2026, an estimated $22.8K.
  • Sanofi made up ﹤0.01% of Lido Advisors's portfolio in Q1 2026, its #1718 holding.
  • Lido Advisors first reported a position in Sanofi in Q2 2023 and has held it in 12 quarters since.
  • Lido Advisors's Sanofi position peaked at $407K in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.